ArticleThe Journal of antimicrobial chemotherapy2018

Characterization of the impact of rpoB mutations on the in vitro and in vivo competitive fitness of Clostridium difficile and susceptibility to fidaxomicin.

Sarah A Kuehne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.